查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606696

糖尿病诊断市场：按糖尿病类型、产品类型、糖尿病诊断类型、最终用户划分 - 全球预测 2025-2030

Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖尿病诊断市值为203.7亿美元，预计2024年将达到219.1亿美元，复合年增长率为7.80%，到2030年将达到344.8亿美元。

糖尿病诊断市场包括各种用于识别和监测糖尿病的设备和技术。这包括 HbA1c检测套组，以及新兴技术，例如连续携带式血糖监测设备和非侵入性血糖监测方法。这些诊断的需求源于全球糖尿病盛行率的不断上升，受生活方式因素和老化等人口变化的影响。其用途广泛，包括个人用于糖尿病管理、临床实验室用于诊断和监测以及糖尿病治疗进展的研究。最终用途主要取决于诊断中心、医院和家庭医疗保健机构。

主要市场统计
基准年[2023] 203.7亿美元
预测年份 [2024] 219.1亿美元
预测年份 [2030] 344.8亿美元
复合年增长率（%） 7.80%

该市场的关键成长要素包括技术进步、医疗保健意识的提高以及向预防医学的转变。数位健康的进步，例如将人工智慧整合到糖尿病管理中以实现个人化治疗计划和预测分析，带来了巨大的成长机会。值得注意的机会包括开发可提高患者舒适度和依从性的非侵入性和微创诊断工具。对公司的建议包括投资创新诊断的研发、增加进入新兴市场的机会以及建立技术整合的策略伙伴关係。

挑战包括新设备核准的监管障碍、与先进诊断工具相关的高成本以及不同的地区报销政策。解决这些限制需要齐心协力简化产品核可流程并倡导标准化报销通讯协定。

感测器技术、资料整合和即时监测系统领域存在大量创新机会，以实现更全面的糖尿病管理。在持续的技术进步和对精准医疗日益重视的推动下，市场仍然充满活力。公司可以利用这些见解，透过专注于协作开发并确保适应不断变化的法规环境和新兴市场需求，确保永续成长。

市场动态：快速发展的糖尿病诊断市场的关键市场洞察

供需的动态交互作用正在改变糖尿病诊断市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 随着老年人口的增加，糖尿病盛行率不断上升
    • 家庭自我监测血糖值的成长趋势
    • 政府针对糖尿病的措施和公共卫生宣传活动
  • 市场限制因素
    • 糖尿病诊断设备高成本
  • 市场机会
    • 更多采用就地检验设备
    • 将糖尿病诊断与数位健康平台连接起来的技术持续进步
  • 市场挑战
    • 糖尿病诊断设备的设备精确度与校准问题

波特五力：驾驭糖尿病诊断市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对糖尿病诊断市场的影响

外部宏观环境因素在塑造糖尿病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解糖尿病诊断市场的竞争状况

对糖尿病诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵糖尿病诊断市场供应商绩效评估

FPNV 定位矩阵是评估糖尿病诊断市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘糖尿病诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对糖尿病诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着人口老化的加剧，糖尿病的发生率也随之增加
      • 在家自我监测血糖值的趋势正在增加。
      • 解决糖尿病问题的政府措施和公共卫生宣传活动
    • 抑制因素
      • 糖尿病诊断设备高成本
    • 机会
      • 增加就地检验设备的引进
      • 糖尿病诊断和与数位健康平台连接的技术不断进步
    • 任务
      • 糖尿病诊断设备的准确性与校准问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以糖尿病类型分類的糖尿病诊断药物市场

  • Ⅰ型糖尿病
  • 第二型糖尿病
  • 妊娠糖尿病

第七章糖尿病诊断市场：按产品

  • 生物晶片
  • 血糖值监测仪
  • 套件
  • 采血针

第八章以糖尿病诊断药物类型分類的糖尿病诊断药物市场

  • 血糖值测试
  • 空腹血糖值测试
  • 醣化血红素(A1C) 测试
  • 口服葡萄糖耐受试验（OGTT）

第九章糖尿病诊断市场：依最终使用者分类

  • 诊断中心
  • 家庭护理设置
  • 医院

第十章北美和南美糖尿病诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区糖尿病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲糖尿病诊断药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Diabetomics, Inc.
  • Diazyme Laboratories Inc
  • F. Hoffmann-La Roche Ltd.
  • ICON PLC
  • Medtronic PLC
  • Menarini Group
  • Nova Biomedical Corporation
  • Prestige Diagnostics
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers AG
  • Sinocare, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech PLC
Product Code: MRR-2A0283E25680

The Diabetes Diagnostics Market was valued at USD 20.37 billion in 2023, expected to reach USD 21.91 billion in 2024, and is projected to grow at a CAGR of 7.80%, to USD 34.48 billion by 2030.

The diabetes diagnostics market encompasses a wide range of devices and technologies used to identify and monitor diabetes. This includes glucose monitoring devices, both continuous and portable, as well as HbA1c testing kits, and newly emerging technologies like non-invasive glucose monitoring methods. The necessity of these diagnostics stems from the increasing global incidence of diabetes influenced by lifestyle factors and demographic changes, including aging populations. Applications are vast, including personal use for diabetes management, clinical laboratory use for diagnosis and monitoring, and research concerning diabetes treatment advancements. End-use primarily varies between diagnostic centers, hospitals, and home healthcare settings.

KEY MARKET STATISTICS
Base Year [2023] USD 20.37 billion
Estimated Year [2024] USD 21.91 billion
Forecast Year [2030] USD 34.48 billion
CAGR (%) 7.80%

Key growth influencers in this market include advancements in technology, increasing healthcare awareness, and a shift toward preventive healthcare. Digital health advancements, such as the integration of AI in diabetes management for personalized treatment plans and predictive analytics, present substantial growth opportunities. Noteworthy opportunities include the development of non-invasive and minimally invasive diagnostic tools which cater to patient comfort and compliance. Recommendations for businesses include investing in R&D for innovative diagnostic methods, expanding access to emerging markets, and forming strategic partnerships for technology integration.

Challenges include regulatory hurdles for new device approvals, high costs associated with advanced diagnostic tools, and variable reimbursement policies across regions. Addressing these limitations requires concerted efforts in streamlining the product approval process and advocating for standardized reimbursement protocols.

Innovation opportunities are rich in the areas of sensor technology, data integration, and real-time monitoring systems, enabling more comprehensive diabetes management. The market remains dynamic, driven by continuous technological progress and a growing emphasis on precision medicine. Businesses can leverage these insights by focusing on collaborative developments and ensuring adaptability to changing regulatory environments and emerging market demands, thus ensuring sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Diagnostics Market

The Diabetes Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes with increasing geriatric population
    • Increasing trend of self-monitoring blood glucose levels at home
    • Government initiatives and public health campaigns to address diabetes
  • Market Restraints
    • High cost of diabetes diagnostic devices
  • Market Opportunities
    • Increasing adoption of point-of-care testing devices
    • Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
  • Market Challenges
    • Device accuracy and calibration issues with diabetes diagnostic device

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Diagnostics Market

A detailed market share analysis in the Diabetes Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Diagnostics Market

A strategic analysis of the Diabetes Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Apex Biotechnology Corporation, ARKRAY, Inc., B. Braun Melsungen AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Diabetomics, Inc., Diazyme Laboratories Inc, F. Hoffmann-La Roche Ltd., ICON PLC, Medtronic PLC, Menarini Group, Nova Biomedical Corporation, Prestige Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., Siemens Healthineers AG, Sinocare, Inc., Terumo Corporation, Tosoh Bioscience, Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Diabetes Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diabetes Type, market is studied across Diabetes I, Diabetes II, and Gestational Diabetes.
  • Based on Product, market is studied across Biochips, Glucose Monitors, Kits, and Lancets.
  • Based on Diabetes Diagnostics Type, market is studied across Blood Glucose Test, Fasting Plasma Glucose Test, Glycated hemoglobin (A1C) Test, and Oral Glucose Tolerance Test (OGTT).
  • Based on End-User, market is studied across Diagnostic Centers, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes with increasing geriatric population
      • 5.1.1.2. Increasing trend of self-monitoring blood glucose levels at home
      • 5.1.1.3. Government initiatives and public health campaigns to address diabetes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diabetes diagnostic devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of point-of-care testing devices
      • 5.1.3.2. Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Device accuracy and calibration issues with diabetes diagnostic device
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetes Diagnostics Market, by Diabetes Type

  • 6.1. Introduction
  • 6.2. Diabetes I
  • 6.3. Diabetes II
  • 6.4. Gestational Diabetes

7. Diabetes Diagnostics Market, by Product

  • 7.1. Introduction
  • 7.2. Biochips
  • 7.3. Glucose Monitors
  • 7.4. Kits
  • 7.5. Lancets

8. Diabetes Diagnostics Market, by Diabetes Diagnostics Type

  • 8.1. Introduction
  • 8.2. Blood Glucose Test
  • 8.3. Fasting Plasma Glucose Test
  • 8.4. Glycated hemoglobin (A1C) Test
  • 8.5. Oral Glucose Tolerance Test (OGTT)

9. Diabetes Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Diabetes Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diabetes Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diabetes Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Acon Laboratories, Inc.
  • 4. AgaMatrix, Inc.
  • 5. Apex Biotechnology Corporation
  • 6. ARKRAY, Inc.
  • 7. B. Braun Melsungen AG
  • 8. Beckman Coulter, Inc.
  • 9. Becton, Dickinson and Company
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Danaher Corporation
  • 12. Diabetomics, Inc.
  • 13. Diazyme Laboratories Inc
  • 14. F. Hoffmann-La Roche Ltd.
  • 15. ICON PLC
  • 16. Medtronic PLC
  • 17. Menarini Group
  • 18. Nova Biomedical Corporation
  • 19. Prestige Diagnostics
  • 20. Sanwa Kagaku Kenkyusho Co, Ltd.
  • 21. Siemens Healthineers AG
  • 22. Sinocare, Inc.
  • 23. Terumo Corporation
  • 24. Tosoh Bioscience, Inc.
  • 25. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. DIABETES DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETES DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY FASTING PLASMA GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GLYCATED HEMOGLOBIN (A1C) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ORAL GLUCOSE TOLERANCE TEST (OGTT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023